Vitalis Group SA Business Plan › Section 1 › Executive Summary

1.1 The Opportunity

South Africa has the deepest insurance market on the African
continent — a gross written premium pool of approximately ZAR 581
billion in 2024 — yet remains a market of pronounced contrasts.
Insurance penetration sits at 13.7% of GDP (one of the highest
globally), but this aggregate figure masks the fact that almost half of
working-age adults remain without meaningful life or short-term cover,
that primary medical scheme membership covers only around 16% of the
population, and that the traditional industry’s expense and combined
ratios have deteriorated structurally over the past decade. The industry
is, simultaneously, large and underpenetrated; profitable for the few
and inaccessible to the many.

Vitalis Group South Africa (Pty) Ltd (“Vitalis” or the “Company”) has
been formed to capture this opportunity. The Company will operate a
fully integrated, technology-led financial services platform that
combines health, life and short-term insurance with digital banking,
investment products, and a proprietary behavioural-wellness engine. The
model is explicitly inspired by Discovery Limited’s shared-value
architecture — proven over more than two decades to deliver structurally
lower claims ratios, higher retention, and superior lifetime value per
customer — and is adapted to a new entrant building from a clean
technology base.

1.2 The Vitalis Proposition

Vitalis intends to compete on three differentiators that incumbents
find difficult to replicate at speed:

• A behavioural shared-value model — customers
  earn rewards and pricing benefits for measurable healthy, safe and
  financially-disciplined behaviour, creating a self-reinforcing loop of
  reduced claims, increased margin and reinvestment into customer
  incentives.
• A unified, cloud-native technology stack — every
  product line and every customer touchpoint runs on a single modern
  platform, eliminating the legacy-system tax that consumes 18–22% of
  operating cost at established insurers.
• A multi-product ecosystem with cross-sell
  economics — Vitalis targets a Year-5 cross-sell ratio above 2.4
  products per active customer, materially raising lifetime value while
  diluting customer acquisition cost.

1.3 Financial Highlights

The Company is raising ZAR 1.0 billion in Series A equity to fund
regulatory capital, technology build, customer acquisition, and the
first 24 months of operating losses. A summary of the five-year
financial trajectory is set out below; the full plan is presented in
Sections 15 to 19.

1.4 Investment Highlights

• Large, established market with structural pockets of
  opportunity. South Africa is Africa’s largest insurance market
  by some margin, but customer satisfaction scores trail global benchmarks
  and Net Promoter Scores at incumbents are persistently low.
• Validated business model. The shared-value
  insurance model has been demonstrated empirically — Discovery’s
  integrated cohorts show mortality and morbidity outcomes that improve
  materially against control populations, with measurable claims cost
  benefits.
• Capital-efficient build. Cloud-native
  architecture, fronting / reinsurance relationships, and an embedded
  distribution model deliver materially lower capital intensity than a
  like-for-like legacy build.
• Experienced founding team. The proposed
  executive team combines senior actuarial, technology, banking and
  distribution leadership with cumulative sector experience of more than
  120 years across South African and international insurers.
• Path to liquidity. A JSE Main Board IPO is
  targeted for Year 7 with a base-case valuation of ZAR 18–22 billion;
  alternative trade-sale and recapitalisation paths are credible given
  strategic interest from global insurers and South African
  banks.

1.5 Risks and Mitigants — At a Glance

The principal risks to the plan are: regulatory delay; underwriting
losses materially exceeding plan; technology execution risk; talent
attraction and retention; and macroeconomic deterioration. Each is
treated in detail in Section 13. A summary mapping is shown in the table
below.

1.6 Use of Proceeds (Summary)

The ZAR 1.0 billion Series A is allocated to fund licensing, build,
launch and scale to EBITDA break-even (estimated month 32 from financial
close). The allocation reflects regulator-mandated minimum capital,
prudent buffers, and a deliberate over-investment in technology to
underwrite the long-term competitive moat.

1.7 What This Document Covers

The remainder of this Business Plan is structured to take a
sophisticated investor or senior lender progressively from market
context (Sections 3–5), through business model and product (Sections
6–9), into regulation, operations, governance and risk (Sections 10–13),
and finally into the implementation roadmap, financial plan, scenario
analysis and investor returns (Sections 14–20). Appendices contain the
glossary and assumption schedule.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Vitalis Group South Africa (Pty) Ltd.